US 12318356
Use of cannabinoids in the treatment of epilepsy
granted A61KA61K31/05A61K31/352
Quick answer
US patent 12318356 (Use of cannabinoids in the treatment of epilepsy) held by JAZZ PHARMACEUTICALS RESEARCH UK LIMITED expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED
- Grant date
- Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/05, A61K31/352, A61K31/658, A61K45/06